Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02002455 | Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRI | PHASE2 | COMPLETED | 26 | — | — | Dec 1, 2013 | Jun 1, 2016 | Oct 21, 2016 | 1 | Finland |
By comparing tracer uptake and imaging findings at MRI in each sextant with macroslices obtained at radical prostatectomy sensitivity, specificity, positive and negative predictive value and accuracy will be calculated
| Arm | Type | Description |
|---|---|---|
| Multimodality imaging | EXPERIMENTAL | PET/CT, PET/MRI, mpMRI |
| Name | Type | Description |
|---|---|---|
| PET/CT, PET/MRI, mpMRI | DEVICE | FACBC dose 370 megabecquerel (MBq) |
Inclusion Criteria: * Age: 50 to 85 years old * Language spoken: Finnish or Swedish * Diagnosis: Histologically confirmed adenocarcinoma of prostate * Adequate histological sampling consisting of at least 3 biopsy samples from each lobe * No previous surgical, radiation or endocrine treatment for p...